Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 115.51M P/E - EPS this Y 37.50% Ern Qtrly Grth -
Income -52.15M Forward P/E -2.63 EPS next Y 25.00% 50D Avg Chg 17.00%
Sales 49.09M PEG - EPS past 5Y - 200D Avg Chg -8.00%
Dividend N/A Price/Book 25.34 EPS next 5Y - 52W High Chg -51.00%
Recommedations 1.50 Quick Ratio 1.02 Shares Outstanding 114.69M 52W Low Chg 54.00%
Insider Own 59.53% ROA -26.89% Shares Float 39.06M Beta 1.12
Inst Own 11.23% ROE -414.09% Shares Shorted/Prior 315.04K/181.14K Price 1.47
Gross Margin 73.50% Profit Margin -106.23% Avg. Volume 75,064 Target Price 3.50
Oper. Margin -46.67% Earnings Date May 8 Volume 60,623 Change 2.80%
About Biodesix, Inc.

Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR and NGS, and VeriStrat tests, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to establish the patient's prognosis and help guide treatment decisions. In addition, the company, through its partnership with Bio-Rad Laboratories, Inc., provides Bio-Rad SARS-CoV-2 ddPCR, a COVID-19 Test under Biodesix WorkSafe testing program; and Platelia SARS-CoV-2 Total Ab test, an antibody test for detecting a B-cell immune response to SARS-CoV-2 that indicate recent or prior infection. Further, it offers diagnostic and clinical research, as well as clinical trial testing services to biopharmaceutical companies; and discovers, develops, and commercializes companion diagnostics. The company was formerly known as Elston Technologies, Inc. and as changed to Biodesix, Inc. in 2006. Biodesix, Inc. was incorporated in 2005 and is headquartered in Louisville, Colorado.

Biodesix, Inc. News
04/24/24 Biodesix to Report First Quarter 2024 Financial Results on May 8, 2024
04/13/24 The recent US$4.0m market cap decrease is likely to have disappointed insiders invested in Biodesix, Inc. (NASDAQ:BDSX)
04/09/24 Biodesix to Present New Data on Liquid Biopsy Technologies at AACR 2024 Annual Meeting
04/05/24 Biodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private Placement
03/25/24 Biodesix Announces New Master Collaborative Research Agreement with Leading US Cancer Center
03/04/24 Biodesix, Inc. (NASDAQ:BDSX) Q4 2023 Earnings Call Transcript
03/03/24 Biodesix Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
03/01/24 Q4 2023 Biodesix Inc Earnings Call
03/01/24 Biodesix Inc (BDSX) Reports Strong Growth in Lung Diagnostic Test Volume and Gross Profit Margin
03/01/24 Biodesix Announces Fourth Quarter and Fiscal Year 2023 Results and Business Highlights
02/26/24 Biodesix to Participate in the TD Cowen 44th Annual Health Care Conference
02/16/24 Biodesix to Report Fourth Quarter and Full Year 2023 Financial Results on March 1, 2024
02/13/24 Biodesix Inc CEO Scott Hutton Sells 64,390 Shares
07:41 AM One Biodesix Insider Raised Their Stake In The Previous Year
01/26/24 3 Penny Stocks to Turn $999 Into $1 Million: January 2024
01/04/24 Walgreens Boots (WBA) Q1 Earnings Top Estimates, Margins Down
11/27/23 Zacks Industry Outlook Highlights Medpace, Doximity and Biodesix
11/24/23 3 Medical Services Stocks to Buy as Industry Trends Improve
11/14/23 Biodesix Enhances Access to Nodify Lung® Testing with Launch of New Blood Draw Method
11/09/23 Biodesix to Participate in Two Upcoming Investor Conferences in November
BDSX Chatroom

User Image Stock_Titan Posted - 04/24/24

$BDSX Biodesix to Report First Quarter 2024 Financial Results on May 8, 2024 https://www.stocktitan.net/news/BDSX/biodesix-to-report-first-quarter-2024-financial-results-on-may-8-wvpt1nd0oy7v.html

User Image DonCorleone77 Posted - 04/23/24

$BDSX Biodesix files to sell 30.43M shares of common stock for holders

User Image Jasooon Posted - 04/10/24

$BDSX, back to buy zone for me

User Image Stock_Titan Posted - 04/09/24

$BDSX Biodesix to Present New Data on Liquid Biopsy Technologies at AACR 2024 Annual Meeting https://www.stocktitan.net/news/BDSX/biodesix-to-present-new-data-on-liquid-biopsy-technologies-at-aacr-nl0yo448fqgu.html

User Image Michelleinvestor Posted - 04/07/24

$BDSX look at sls this week! Excitement is building for data update at the end of the month!

User Image ChiefOG Posted - 04/05/24

$BDSX 😎

User Image RallyRaider Posted - 04/05/24

$BDSX not bad

User Image Jasooon Posted - 04/05/24

$BDSX, well at least it was oversubscribed....

User Image briefingcom Posted - 04/05/24

$BDSX: Biodesix priced its underwritten offering of 17,391,832 shares of its common stock at a price to the public of $1.15/share https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20240405071941BDSX&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page

User Image RallyRaider Posted - 04/05/24

$BDSX tug of war

User Image RallyRaider Posted - 04/05/24

$BDSX someone with bucks disagrees with this selloff

User Image RallyRaider Posted - 04/05/24

$BDSX added a few shares

User Image RallyRaider Posted - 04/05/24

$BDSX unnecessary roughness

User Image cgbuzz92 Posted - 04/05/24

$BDSX Can someone dumb this down on what this is? Thanks in advance!

User Image BuyOnRedSellOnGreen Posted - 04/05/24

$BDSX doesn't look like that's the case

User Image BuyOnRedSellOnGreen Posted - 04/05/24

$BDSX a raise to pay off the debt?

User Image briefingcom Posted - 04/05/24

Gapping down: $BDSX -7.9% $ATUS -6.6% $HIW -2.6%

User Image DonCorleone77 Posted - 04/05/24

$BDSX Biodesix 17.4M share Spot Secondary priced at $1.15 The deal priced below last closing price of $1.51. TD Cowen, William Blair and Canaccord are acting as joint book running managers for the offering.

User Image Stock_Titan Posted - 04/05/24

$BDSX Biodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private Placement https://www.stocktitan.net/news/BDSX/biodesix-announces-pricing-of-oversubscribed-and-upsized-h9dwlnbqox74.html

User Image Bull638 Posted - 03/25/24

$BDSX

User Image briefingcom Posted - 03/25/24

Gapping up: $MASI +12.3% $NKTX +11% $ATXS +10.3% $BDSX +7.2% $DJT +4.5%

User Image DekmarTrades Posted - 03/25/24

Wow, I am very impressed. I just got a brand new demo of the News Scanner and everything is insane! This is showing up the real time values, current best news, and the hot key words highlighted! $MBRX $ESPR $NKTX $MASI $BDSX

User Image Stock_Titan Posted - 03/25/24

$BDSX Biodesix Announces New Master Collaborative Research Agreement with Leading US Cancer Center https://www.stocktitan.net/news/BDSX/biodesix-announces-new-master-collaborative-research-agreement-with-8nuq9puibmzi.html

User Image Michelleinvestor Posted - 03/25/24

$BDSX get your popcorn and drink and watch $sls this week. News Tuesday morning on blood cancer assets.

User Image Wiz114 Posted - 03/07/24

@BuyOnRedSellOnGreen $BDSX what and when is the next catalysts for this stock

User Image HypnoTrader Posted - 03/04/24

$bdsx Largest shareholder, Orin Hirchman, sold 2.1 million shares last quarter. For all we know he is still selling. On top of that, they are taking on convertible debt, every quarter to cover their losses. So if/when they reach profitability, they may be saddled with enormous debt and/or have diluted original investors by a large factor. So the stock is stuck, has been since 2022, as all the sales increases are being eaten up by new debt and share creation....

User Image RallyRaider Posted - 03/04/24

$BDSX boring IR but everything is sound... give it some time spokesperson sounds optimistic

User Image RallyRaider Posted - 03/04/24

$BDSX 235k nsclc each year, median survival time 10 months keep in mind: BOOMERS have generational equity

User Image RallyRaider Posted - 03/03/24

$BDSX https://investors.biodesix.com/events/event-details/td-cowen-44th-annual-health-care-conference

User Image Ninja_Tradez Posted - 2 months ago

$BDSX You see why NEWS is Import to get early ! Never Miss any alert 🚨Check Discord Link 🔗 on bio

Analyst Ratings
Canaccord Genuity Buy Mar 4, 24
Canaccord Genuity Buy Dec 7, 23
Morgan Stanley Equal-Weight May 12, 22
Cowen & Co. Outperform Apr 20, 22
Morgan Stanley Equal-Weight Nov 17, 21
Morgan Stanley Overweight May 12, 21
Morgan Stanley Overweight Mar 18, 21
Canaccord Genuity Buy Feb 2, 21
William Blair Outperform Nov 23, 20
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
SCHULER JACK W Director Director Aug 21 Buy 1.67 128,363 214,366 30,707,722 08/23/23
Vazquez Chris Chief Accounting Off.. Chief Accounting Officer Aug 08 Sell 1.33 559 743 5,865 08/10/23
Pestano Gary Anthony Chief Development Of.. Chief Development Officer Aug 08 Sell 1.33 1,573 2,092 103,558 08/10/23
O'Kane Kieran Chief Commercial Off.. Chief Commercial Officer Aug 08 Sell 1.33 1,699 2,260 46,692 08/10/23
Hutton Scott President & CEO President & CEO Aug 08 Sell 1.33 13,782 18,330 318,013 08/10/23
Cowie Robin Harper CFO, Sec'y & Treasur.. CFO, Sec'y & Treasurer Aug 08 Sell 1.33 3,577 4,757 131,535 08/10/23
SCHULER JACK W Director Director May 25 Buy 1.3575 52,508 71,280 20,563,212 05/30/23
SCHULER JACK W Director Director May 23 Buy 1.1459 56,782 65,066 20,475,396 05/25/23
Cowie Robin Harper CFO, Sec'y & Treasur.. CFO, Sec'y & Treasurer May 08 Sell 1.57 3,485 5,471 117,365 05/10/23
O'Kane Kieran Chief Commercial Off.. Chief Commercial Officer May 08 Sell 1.57 1,697 2,664 36,757 05/10/23
Siurek Ryan H Chief Accounting Off.. Chief Accounting Officer May 08 Sell 1.57 2,020 3,171 40,268 05/10/23
Hutton Scott President & CEO President & CEO May 08 Sell 1.57 13,782 21,638 240,722 05/10/23
Pestano Gary Anthony Chief Development Of.. Chief Development Officer May 08 Sell 1.57 1,527 2,397 99,460 05/10/23
Pestano Gary Anthony Chief Development Of.. Chief Development Officer Feb 08 Sell 1.8 1,852 3,334 95,933 02/10/23
Hutton Scott President & CEO President & CEO Feb 08 Sell 1.8 16,278 29,300 199,726 02/10/23
Siurek Ryan H Chief Accounting Off.. Chief Accounting Officer Feb 08 Sell 1.8 2,016 3,629 27,161 02/10/23
Cowie Robin Harper CFO, Sec'y & Treasur.. CFO, Sec'y & Treasurer Feb 08 Sell 1.8 4,220 7,596 99,275 02/10/23
O'Kane Kieran Chief Commercial Off.. Chief Commercial Officer Feb 08 Sell 1.8 1,999 3,598 22,993 02/10/23
Kennedy Lawrence T. Jr 10% Owner 10% Owner Nov 21 Buy 1.15 10,869,565 12,500,000 4,355,914 01/05/23
O'Kane Kieran Chief Commercial Off.. Chief Commercial Officer Nov 08 Sell 1.03 1,705 1,756 15,184 11/10/22
Georgantas Robert William III Chief Scientific Off.. Chief Scientific Officer Nov 08 Sell 1.03 1,776 1,829 26,114 11/10/22
Hutton Scott President & CEO President & CEO Nov 08 Sell 1.03 13,777 14,190 106,010 11/10/22
Cowie Robin Harper CFO, Sec'y & Treasur.. CFO, Sec'y & Treasurer Nov 08 Sell 1.03 3,582 3,689 74,529 11/10/22
Pestano Gary Anthony Chief Development Of.. Chief Development Officer Nov 08 Sell 1.03 1,580 1,627 92,732 11/10/22
Siurek Ryan H Chief Accounting Off.. Chief Accounting Officer Nov 08 Sell 1.03 1,725 1,777 14,999 11/10/22
Siurek Ryan H Chief Accounting Off.. Chief Accounting Officer Aug 08 Sell 2.53 1,645 4,162 11,242 08/10/22
Hutton Scott President & CEO President & CEO Aug 08 Sell 2.53 13,634 34,494 75,009 08/10/22
Georgantas Robert William III Chief Scientific Off.. Chief Scientific Officer Aug 08 Sell 2.53 1,686 4,266 22,244 08/10/22
Cowie Robin Harper CFO, Sec'y & Treasur.. CFO, Sec'y & Treasurer Aug 08 Sell 2.53 3,533 8,938 66,537 08/10/22
Pestano Gary Anthony Chief Development Of.. Chief Development Officer Aug 08 Sell 2.53 1,549 3,919 89,258 08/10/22
O'Kane Kieran Chief Commercial Off.. Chief Commercial Officer Aug 08 Sell 2.53 1,673 4,233 11,428 08/10/22
O'Kane Kieran Chief Commercial Off.. Chief Commercial Officer May 09 Sell 1.83 1,583 2,897 7,639 05/11/22
Siurek Ryan H Chief Accounting Off.. Chief Accounting Officer May 09 Sell 1.83 1,947 3,563 7,403 05/11/22
Georgantas Robert William III Chief Scientific Off.. Chief Scientific Officer May 09 Sell 1.83 2,004 3,667 18,283 05/11/22
Hutton Scott President & CEO President & CEO May 09 Sell 1.83 13,278 24,299 43,866 05/11/22
Pestano Gary Anthony Chief Development Of.. Chief Development Officer May 09 Sell 1.83 1,467 2,685 85,753 05/11/22
Cowie Robin Harper CFO, Sec'y & Treasur.. CFO, Sec'y & Treasurer May 09 Sell 1.83 3,338 6,109 58,495 05/11/22
PATIENCE JOHN - - Apr 07 Buy 1.79 279,329 499,999 337,926 04/11/22
Strobeck Matthew Director Director Apr 07 Buy 1.79 1,117,318 1,999,999 769,859 04/11/22
SCHULER JACK W Director Director Apr 07 Buy 1.79 2,793,296 5,000,000 11,256,460 04/11/22
SCHULER JACK W Director Director Dec 30 Buy 4.35 2,298,850 9,999,998 8,463,164 01/31/22
Cowie Robin Harper CFO, Sec'y & Treasur.. CFO, Sec'y & Treasurer Jan 13 Option 0.42 5,679 2,385 47,654 01/18/22